Oppenheimer Starts 89bio Inc. (ETNB) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Intel shares fall as competitor reports record results
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
SVB Leerink Starts 89bio Inc. (ETNB) at Outperform
December 9, 2019 7:08 AM ESTSVB Leerink analyst Pasha Sarraf initiates coverage on 89bio Inc. (NASDAQ: ETNB) with a Outperform rating and a price target of $55.00.
For an analyst ratings summary and ratings history on 89bio Inc. click here. For more ratings news on 89bio Inc. click here.
Shares of 89bio Inc. closed at $28.60 yesterday.
... MoreUPDATE: RBC Capital Starts 89bio Inc. (ETNB) at Outperform
December 9, 2019 5:34 AM EST(Updated - December 9, 2019 6:42 AM EST)
(updated to add analyst comments)
RBC Capital analyst Brian Abrahams initiates coverage on 89bio Inc. (NASDAQ: ETNB) with a Outperform rating and a price target of $36.00 and a 'Speculative Risk' qualifier.
The... More



